chevron_leftBack
As of 15 June 2026, Zhejiang Hisoar Pharmaceutical Co., Ltd. has a market cap of $1.48B USD, ranking #8522 globally and #2213 in China.
It ranks #716 in the Healthcare sector, and #276 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.48BUSD
10.04B CNY
Enterprise Value
$1.52BUSD
10.26B CNY
Revenue (TTM)
$274.61MUSD
1.86B CNY
EBITDA (TTM)
$48.05MUSD
325.16M CNY
Net Income (TTM)
-$10.9MUSD
-73.86M CNY
EBITDA Margin
17%
Profit Margin
-4%
PS Ratio
5.4
PB Ratio
2.0
EV/EBITDA
29.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Guorui Xu
open_in_new
Employees
2,611
Founded
1966
Website
hisoar.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -3.7% | -5.1% | -8.2% | 2.7% | 16% | 33% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002099
浙江海翔药业股份有限公司 Class A
ISIN: CNE000001PY2
Shares Out.:
Shares Outstanding:
1.555B1
Shares Float:
808.868M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
6.34 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Zhejiang Hisoar Pharmaceutical Co., Ltd.
Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and dyes in China and internationally. The company offers antibiotics, cardiovascular, hypoglycemic, fine chemicals, formulations, intermediates, and other products. It also provides dyestuff, and intermediates of dyestuff and pigment; and manufactures environmental protection related equipment, medical chemical supplies and appliances, and other chemical intermediates. The company was founded in 1966 and is based in Taizhou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
4K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
3K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
2K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
1K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
1K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
981%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
51K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
37K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
24K%
|
97.4
|
|
SIX: RO
|
$321.52B
22K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
19K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
18K%
218.9B CHF
|
20.5
|
chevron_leftBack